Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.9B | 12.4B | 12.9B | 10.3B |
Cost of revenue | 7.8B | 10.6B | 11.1B | 8.9B |
Gross profit | 1.1B | 1.7B | 1.7B | 1.4B |
Operating expense | ||||
Research & development | 579.4M | 623.9M | 538.2M | 505.5M |
Selling general and admin | 408.0M | 573.7M | 440.8M | 408.7M |
Other operating expenses | — | — | — | — |
Operating income | 107.2M | 514.6M | 755.0M | 438.7M |
Non operating interest income | ||||
Income | 73.5M | 59.2M | 50.8M | 77.2M |
Expense | 21.9M | 22.8M | 24.0M | 26.5M |
Other income expense | — | — | — | — |
Pretax income | 490.5M | 973.8M | 864.1M | 781.8M |
Tax provision | 92.4M | 230.1M | 153.1M | 207.7M |
Net income | 398.0M | 743.7M | 711.0M | 574.1M |
Basic EPS | 1.4 | — | 2.6 | 2.2 |
Diluted EPS | 1.3 | — | 2.4 | 2.0 |
Basic average shares | 248.9M | — | 241.9M | 220.5M |
Diluted average shares | 265.8M | — | 261M | 244.5M |
EBITDA | 718.2M | 1.2B | 1.1B | 1.0B |
Net income from continuing op. | 490.5M | 973.8M | 864.1M | 781.8M |
Minority interests | -44.5M | -83.6M | -84.6M | -82.5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |